Market Closed -
Other stock markets
|
After market 19:53:46 | |||
764 USD | +0.83% | 762.2 | -0.23% |
05-14 | Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs | RE |
05-14 | Argus Adjusts Price Target on Eli Lilly to $840 From $770 | MT |
ETFs positioned on Eli Lilly and Company
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.77% | 265 M€ | +5.42% | - | |
0.74% | 57 M€ | +21.00% | - | |
0.72% | 14 M€ | +16.19% | - | |
0.72% | 1,487 M€ | +7.21% | - | |
0.72% | 1 M€ | -.--% | ||
0.66% | 8 M€ | +5.48% | - | |
0.60% | 9 M€ | +9.41% | ||
0.58% | 727 M€ | +8.60% | ||
0.58% | 2,517 M€ | +12.16% | - | |
0.54% | 283 M€ | +19.85% | ||
0.50% | 15 M€ | -1.62% | - | |
0.48% | 0 M€ | 0.00% | - | |
0.47% | 571 M€ | +7.35% | - | |
0.46% | 7 M€ | +0.11% | - | |
0.43% | 391 M€ | +8.75% | - | |
0.43% | 25 M€ | +3.73% | - | |
0.42% | 9 M€ | +9.94% | - | |
0.42% | 34 M€ | +8.28% | - | |
0.36% | 4 M€ | -.--% | - | |
0.36% | 35 M€ | +8.00% | - | |
0.36% | 169 M€ | -0.42% | - | |
0.34% | 45 M€ | 0.00% | - | |
0.33% | 112 M€ | +4.91% | - | |
0.31% | 306 M€ | +5.93% | - | |
0.31% | 39 M€ | +5.31% | - | |
0.29% | 6 M€ | +3.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.06% | 688B | |
+31.84% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.36% | 239B | |
+9.99% | 210B | |
-6.99% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- LLY Stock
- Funds and ETFs Eli Lilly and Company